Sökresultat

Popular Science SummaryWe are all familiar with the idea that living organisms are made of atoms and molecules. But not everyone knows that one of those molecules that are crucial for our lives are proteins. And no, they aren’t just something we have to eat. Proteins are an essential molecule which form our cells, together with fat, sugars, and nucleic acids. Proteins are the workforce of the cell

https://www.multipark.lu.se/article/amyloid-oligomers-capturing-threat-between-disorder-and-order-phd-thesis-lei-ortigosa-pascual - 2026-01-01

A commercially available blood test has now been trialled in routine healthcare. “The blood test showed about 90% reliability even in primary care. This may have major implications for all those individuals who seek help for memory loss and suspected Alzheimer’s,” say the researchers at Lund University in Sweden behind the study. Alzheimer’s disease affects one in five women and one in ten men ove

https://www.multipark.lu.se/article/groundbreaking-alzheimers-blood-test-proves-highly-effective-primary-healthcare - 2026-01-01

Neuroinflammation plays a significant role in neurodegenerative disorders. That is why MultiPark researchers collaborates across research teams. ”Neuroinflammatory pathways in neurodegenerative diseases” is a new special interest group (SIG) to elucidate molecular and genetic aspects in a rapidly growing research area. Malin Wennström explains how she convenes the joint effort. Can you briefly des

https://www.multipark.lu.se/article/neuroinflammatory-pathways-neurodegenerative-diseases-special-interest-group - 2026-01-01

Digital tools within healthcare are developing faster than ever before. Therefore, MultiPark researchers gather across groups to develop implementable tools for the diagnosis and prognosis of neurodegenerative disorders. “Digital tools to reliably evaluate cognitive and neurological symptoms” is a new special interest group (SIG) convened by Maria H Nilsson. Here, she tells about the group’s visio

https://www.multipark.lu.se/article/digital-tools-evaluate-symptoms-special-interest-group - 2026-01-01

Recent discoveries have shown that it is possible to convert one cell type into another, typically by forced expression of lineage specific transcription factors. That is why MultiPark researchers with expertise in reprogramming gather across research groups. Cellular reprogramming is a new special interest group (SIG) addressing scientific and technological needs to apply these methods in researc

https://www.multipark.lu.se/article/cellular-reprogramming-special-interest-group - 2026-01-01

Breakthroughs of new pharmacological treatments requires translational research – from bench to bed. That is why MultiPark researchers gather from experimental to clinical research teams. The special interest group ”Regenerative pharmacology” fosters an integrative approach for future pharmacological developments. Karsten Ruscher explains how he convenes the joint effort. Can you shortly describe

https://www.multipark.lu.se/article/regenerative-pharmacology-special-interest-group - 2026-01-01

In the podcast series "Meet our scientists", young MultiPark researchers interview our research group leaders about their academic journey and main scientific focus. Listen to the new episode where Professor Malin Parmar describes the experimental road to the ongoing stem cell trials in Lund. I the latest episode (nr. 14), Lluís welcomes the renowned Professor Malin Parmar. She leads the different

https://www.multipark.lu.se/article/meet-our-scientists-continuation-parkinsons-revolution - 2026-01-01

Receiving grants from the Swedish Research Council is viewed as a quality mark and one of the critical steps for young scientists to establish an independent research group. Recently, five of MultiPark’s research leaders were awarded funding for their projects. This year’s support from the Swedish Research Council encouraged MultiPark’s ambition to be a multidisciplinary research area. Projects ra

https://www.multipark.lu.se/article/multipark-scientists-granted-support-swedish-research-council - 2026-01-01

Malin Parmar, professor of cellular neuroscience leading one of MultiPark's research groups, along with three researchers in Italy and Denmark, has been awarded the prestigious ERC Synergy Grant worth EUR 10 million. The four researchers aim to develop custom-made neurons from stem cells for cell therapies to treat Parkinson’s or Huntington’s disease. “We want to develop a completely new concept i

https://www.multipark.lu.se/article/erc-synergy-grant-development-custom-made-stem-cell-therapies-neurodegenerative-disorders - 2026-01-01

Patients with frontotemporal dementia often lack the ability to empathize. A study at Lund University and Karolinska Institutet has now shown that these patients do not show the same brain activity as healthy individuals when they witness the pain of others, a finding that it is hoped will increase understanding of this specific dementia disease. This is an important piece of the puzzle now fallin

https://www.multipark.lu.se/article/new-study-shows-how-dementia-affects-brains-ability-empathise - 2026-01-01

A team of international researchers led by Professor Johan Jakobsson at Lund University has secured a 52 million SEK grant from the Aligning Science Across Parkinson’s (ASAP) initiative, in partnership with the Michael J Fox Foundation to investigate how mobile genetic elements —commonly referred to as "jumping genes"—contribute to neuroinflammation and the progression of Parkinson’s disease. Jump

https://www.multipark.lu.se/article/52-million-sek-goes-uncovering-genetic-drivers-parkinsons-disease - 2026-01-01

Dear colleagues and collaborators,As we approach the end of 2024, I believe that we can look back with pride on the many things that we have achieved together this year. We would like to thank all of you for your vital contributions to our research environment, encompassing diverse roles and capacities. Next year is poised to be a particularly eventful year for MultiPark. On December 12, the Swedi

https://www.multipark.lu.se/article/seasons-greetings-multipark - 2026-01-01

Dear colleagues and collaborators,Welcome to a new year with MultiPark!Our Management group has now resumed its activities at full pace, and we are happy to share some fresh information as follows:(i) The dates for this year´s meetings of the MultiPark Board and Steering group have been set and posted under this link https://www.multipark.lu.se/about-multipark/management. We welcome Oxana Klementi

https://www.multipark.lu.se/article/kicking-year-packed-program-ahead - 2026-01-01

Don't miss the latest episode of MultiPark's podcast Meet our scientists. MultiPark's newest research group leader, Henrik Ahlenius, shares his expertise about stem cells in aging and neurodegenerative diseases. In this episode, Henrik explains the fascinating interplay between aging, neurodegenerative diseases and stem cells - critical areas of study that Henrik Ahlenius has passionately pursued

https://www.multipark.lu.se/article/meet-our-scientists-podcast-henrik-ahlenius-about-stem-cells-aging-and-neurodegeneration - 2026-01-01

This week marked the kickoff of MultiPark's Advanced Neuroscience Course. In this exclusive program, students from around the world unite to explore neuroscience and the complexities of neurodegenerative diseases. During the Advanced Neuroscience Course, students gain insights from leading researchers and get hands-on lab experience, working closely with labs that match their interests. The course

https://www.multipark.lu.se/article/advanced-neuroscience-course-future-neuroscientists - 2026-01-01

A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta — a hallmark of Alzheimer’s disease. The findings suggest that vascular dysfunction could be an early driver in neurodegenerative disorders rather than being caused by neuronal damage. The study is published in Acta Neuropathologica. An increased risk o

https://www.multipark.lu.se/article/cracking-alzheimers-code-how-brain-trauma-triggers-disease - 2026-01-01

This year, MultiPark has the pleasure of welcoming two new research groups. The Mackenzie Lab aims to decode the neurobiological underpinnings of emotion through experimental studies in animal models. Jacob Vogel’s team uses AI to analyze clinical data for improved understanding as well as patient-tailored diagnosis and care of neurodegenerative disease patients. Say hello to Åsa Mackenzie and Jac

https://www.multipark.lu.se/article/multipark-grows-new-research-groups - 2026-01-01

What role does an inflammatory protein have in disease development? Which neuronal circuits cause different symptoms? How may diabetes affect Parkinson’s disease? Can motor signs be identifies early in individuals at risk for the disease? And how should patients in very advanced disease stages be treated to maintain their quality of life? These questions may soon have answers thanks to several ong

https://www.multipark.lu.se/article/molecule-patient-six-promising-projects-advance-parkinsons-research - 2026-01-01

Researchers at Lund University and Washington University have identified a blood marker that reflects the amount of Alzheimer’s pathology in the brain. This discovery may play a key role in determining who is most likely to benefit from the new Alzheimer’s drugs. In brief:A newly discovered blood marker, MTBR-tau243, can reveal how much Alzheimer’s disease pathology is present in the brain. The hi

https://www.multipark.lu.se/article/new-reliable-blood-marker-reveals-extent-alzheimers-pathology-brain - 2026-01-01

A simpler method of analysing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund University in Sweden. “This is a major step in bringing simple blood tests for Alzheimer’s disease into the healthcare system globally,” say the researchers behind the study. In brief:The blood-based marker (P-tau217) may start to change several years before the onset of Al

https://www.multipark.lu.se/article/more-opportunities-test-alzheimers-using-new-analytical-method - 2026-01-01